Literature DB >> 12117990

CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes.

Rhonda Larkin1, Christopher D Benjamin, Yen-Ming Hsu, Qing Li, Lynn Zukowski, Richard F Silver.   

Abstract

Human monocytes displayed increased expression of CD40 following infection with virulent Mycobacterium tuberculosis. Nevertheless, soluble CD40 ligand (CD40L; also designated CD154) had no effect on the intracellular growth of the organism. Restriction of the intracellular growth of M. tuberculosis by peripheral blood lymphocytes and antigen-specific CD4+ T-cell lines likewise was not reduced by blocking anti-CD40L monoclonal antibody 5c8.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117990      PMCID: PMC128186          DOI: 10.1128/IAI.70.8.4716-4720.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

2.  Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction.

Authors:  U Shu; M Kiniwa; C Y Wu; C Maliszewski; N Vezzio; J Hakimi; M Gately; G Delespesse
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

Review 3.  Interferon-gamma and interleukin-12 pathway defects and human disease.

Authors:  S E Dorman; S M Holland
Journal:  Cytokine Growth Factor Rev       Date:  2000-12       Impact factor: 7.638

4.  Interleukin-12 regulates the production of Bacille Calmette-Guérin-induced interferon-gamma from human cells in a CD40-dependent manner.

Authors:  P Méndez-Samperio; H E Ayala-Verdin; A Trejo-Echeverria
Journal:  Scand J Immunol       Date:  1999-07       Impact factor: 3.487

5.  Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals.

Authors:  R F Silver; R S Wallis; J J Ellner
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

6.  Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).

Authors:  S Lederman; M J Yellin; A Krichevsky; J Belko; J J Lee; L Chess
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

8.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.

Authors:  J Chan; Y Xing; R S Magliozzo; B R Bloom
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

9.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

Authors:  M R Alderson; R J Armitage; T W Tough; L Strockbine; W C Fanslow; M K Spriggs
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  4 in total

1.  Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung.

Authors:  Gwo-Hsiao Chen; John J Osterholzer; Mun Y Choe; Roderick A McDonald; Michal A Olszewski; Gary B Huffnagle; Galen B Toews
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

2.  CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.

Authors:  Manuela Flórido; Ana Sofia Gonçalves; M Salomé Gomes; Rui Appelberg
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

3.  CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.

Authors:  Georgiana M Klug-Micu; Steffen Stenger; Andrea Sommer; Philip T Liu; Stephan R Krutzik; Robert L Modlin; Mario Fabri
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

4.  Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa.

Authors:  Sarah J Campbell; Pardis Sabeti; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Lisse; Giorgio Sirugo; Richard Bellamy; Steve Bennett; Peter Aaby; Keith P W J McAdam; Oumou Bah-Sow; Christian Lienhardt; Adrian V S Hill
Journal:  Immunogenetics       Date:  2003-08-29       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.